Virtue VC
Virtue VC is a healthcare-focused venture capital firm based in Austin, Texas, founded in 2021. The firm is led by founder and managing partner Sean Doolan, who brings a wealth of experience in the healthcare sector. Virtue VC is committed to supporting elite founders at the earliest stages of their ventures, aiming to radically transform the healthcare ecosystem.
The firm specializes in pre-seed and seed investments, typically writing initial checks ranging from $500,000 to $4 million. Virtue VC focuses on sectors such as digital health, AI, biotech, and SaaS, primarily investing in the United States but remaining open to global opportunities. The firm manages two funds: Fund I with $31.25 million and Fund II with $55.75 million, targeting a portfolio of about 25 companies.
Notable investments by Virtue VC include companies that are at the forefront of healthcare innovation, although specific portfolio companies were not detailed in the available sources.
Vis Caeli Impact Lab
Vis Caeli Impact Lab is a venture capital firm dedicated to supporting bold entrepreneurs in the blockchain and AI sectors. Based in Europe, the firm was founded by Violetta Chekan, who brings over 13 years of experience in startups and venture capital. The team is committed to driving innovation through investments in decentralized technologies, aiming to be a transformative force in the emerging blockchain space.
The firm primarily invests in pre-seed and early-stage companies that are focused on developing groundbreaking blockchain technologies. Vis Caeli Impact Lab is particularly interested in ventures building Web3 solutions, with a specific interest in sectors such as AI and crypto. The typical investment size ranges from $0-1 million, reflecting their focus on early-stage ventures.
Notable portfolio companies include Humanos, a decentralized health data command center in the blockchain in healthcare domain. The firm continues to shape the future of the internet with strategic investments, while Violetta Chekan's expertise and industry recognition add significant value to their investment approach.
Vis Mundi
Vis Mundi is a private equity firm based in Dubai, United Arab Emirates, founded in 2014. The firm is led by a team of professionals with a mix of commercial, operational, and financial expertise. They focus on building a portfolio of unique investment opportunities in the Fast Moving Consumer Goods (FMCG) and Consumer Healthcare sectors across high-growth geographies, particularly in Africa and other emerging markets. Vis Mundi is known for its commitment to ethical standards and long-term value creation.
The firm primarily invests in the healthcare, household care, personal care, and food & beverages sectors. They target privately-held companies and are actively seeking new investments. Vis Mundi has a presence in several key locations, including Cairo, Lagos, Istanbul, Moscow, and Dubai. The firm operates through its subsidiary, Vis Mundi Advisors DMCC, which is regulated by the Dubai Multi Commodities Centre Authority.
Notable investments by Vis Mundi include Power Horse Global - a beverage company, EgySwiss - a food products company, Kcal Group - a health-focused food company, Warehouse Gym - a leisure facilities provider, and Country Hill International - a specialty retail company. These investments highlight Vis Mundi's focus on sectors that align with their strategic goals in high-growth markets.
Visible Hands
Visible Hands is a venture capital firm based in Boston, Massachusetts, founded in 2020. The firm is dedicated to investing in underrepresented founders, particularly women and people of color. They operate with a small team of professionals and focus on providing bespoke support to their founders, including branding and sales coaching. Visible Hands is known for its unique approach to identifying and nurturing exceptional talent through competitive grant partnerships and a vast network of repeat builders.
The firm primarily invests in sectors such as medical devices, wearables, property technology, education technology, Web3, SaaS, and mobility. They focus on pre-seed and seed stages, with typical check sizes ranging from $25,000 to $175,000. Visible Hands has a strong presence in the USA and has raised over $50 million through their portfolio companies. They run notable programs like VHNYC and VHBOS, which support early-stage, underrepresented founders.
Visible Hands has made significant investments in companies like Parfait, which is disrupting the wig industry, and Sign-Speak, a communication software company. Their portfolio includes over 66 companies, with 36 having closed pre-seed and seed rounds. The firm continues to actively seek new investments, aiming to support founders who have historically faced institutional barriers.
Visible Ventures
Visible Ventures is a venture capital firm based in Boston, Massachusetts, founded in 2016. The firm is composed of a small team of four professionals and focuses on investing in companies that are building better paths to wealth, health, and upward mobility, particularly for Gen Z. They differentiate themselves by leveraging a Gen Z advisory network and campus scouts to gain insights into emerging consumer trends and founders.
Visible Ventures invests in sectors such as health, wellness, financial systems, and the future of work. They typically invest in early-stage companies, including Seed and Series A rounds, with an average check size of $1 million. The firm primarily focuses on the USA and Canada. Their investment strategy includes backing non-obvious founders, especially women and diverse teams that mainstream funds might overlook.
Notable investments by Visible Ventures include Archestra - business/productivity software, Realm - household products, UpSmith - business/productivity software, Andromeda Robotics Operations - other hardware, and Poolhouse - other restaurants, hotels, and leisure. These investments highlight their commitment to supporting innovative solutions across various industries.
Vision Brazil Investments
A firm driven by innovation, seeking value in alternative parts of the Brazilian market--Vision Brazil Investments provides qualified international investors with access to a wide range of investments in Special Credit Situations, Agriculture and Renewable Energy
Vision Capital
Vision Capital is a private equity firm based in London, United Kingdom, founded in 1997. The firm is known for pioneering direct portfolio acquisitions and has invested over $2 billion in more than 100 transactions. Vision Capital focuses on creating sustainable value for its stakeholders through a differentiated investment strategy. The firm operates with a small team, emphasizing a tailored approach to investments.
Vision Capital primarily invests in financial services, specialty industrial, and asset-backed consumer businesses across Europe and North America. The firm is actively seeking new investments and is a member of the British Venture Capital Association and Principles for Responsible Investment. Vision Capital's investment strategy includes growth and expansion opportunities, with a focus on buyouts and debt provision.
Notable investments by Vision Capital include Flex'Up - a commercial services provider, OMNIA Protocol - a network management software company, and Vatterott Educational Centers - an educational and training services provider. The firm has also exited investments such as ABL-TECHNIC Group and FDH Infrastructure Services.
Vision Ventures
With Vision Ventures Capital, you can start running your company confidently with the right guidance, financial and marketing resources needed to kick off your dream start-up project. We bring our long and successful years of business experience to the table to help you incorporate and grow your company like a seasoned entrepreneur.
Visionaries club
Visionaries Club is a venture firm that connects top-tier founders with industry leaders and experts. They focus on building a unique network of influential entrepreneurs and industrial family leaders to support startups. The firm emphasizes a culture of obsession and ambition, aiming to redefine the venture capital landscape by rejecting traditional institutional practices.
The firm invests in technology-driven sectors, particularly those that are reshaping industries through innovation. They back companies at various stages of growth, providing support and mentorship from their extensive network of successful entrepreneurs. Their approach is centered on fostering connections that help founders navigate challenges and accelerate their growth.
Notable investments include Lovable - app creation platform, Pigment - business planning tool, and Langdock - AI platform for enterprises. Other portfolio companies include Miro - collaborative whiteboard tool and UiPath - automation software provider.
Visionary Venture Fund
Visionary Venture Fund is a venture capital firm based in Newport Beach, California, with a primary focus on life sciences, particularly in ophthalmology and medical aesthetics. The firm collaborates with Key Opinion Leaders (KOLs), industry experts, and strategic acquirers to gather unparalleled insights, enabling informed investment decisions. This partnership approach sets them apart by leveraging specialized expertise and industry connections to add value to their portfolio companies.
The firm targets investments in companies addressing unmet or underserved markets, focusing on societal impact alongside financial returns. Visionary Venture Fund invests across early to late stages, with a particular emphasis on Series A to commercialization stages, offering check sizes from $5 million to $15 million. The firm operates with a significant focus on the U.S. market, specifically partnering with companies that show potential for significant impact in their targeted sectors.
Notable investments include Aurion Biotech, which focuses on innovative cell therapy for corneal endothelial disease, and Re-Vana Therapeutics, known for its collaboration with a major pharmaceutical firm. Other investments span across emerging technologies within their niche, reflecting their strategic emphasis on transformation in life sciences.